We all know the pandemic accelerated the need for a robust Telehealth services infrastructure. Players in the Telehealth industry saw their membership numbers soar while doing their best to meet the demand; however, it exposed some limitations of the stand-alone services. Soon patients’ needed to buy devices to record biomarkers doctors needed to make an accurate diagnosis, resulting in frustrated doctors feeling “blind” as they’re trying to help and a patient who is unsure about the telehealth consultations due to lack of consistent biomarkers.
In short, remote patient monitoring technology (RPM), despite all of its benefits, lacked the flexibility, connectivity, simplicity, and cost-effectiveness to fill in the gaps. It is time for a new league of medical devices; simple to use, multiple modalities, standardize communication, and ready to easily exchange patient biometrics. This effort is of massive proportions; it will take tireless collaboration across stakeholders in the industry while constantly pushing to simplify the customer experience. Yet, what hat are the benefits of this technology?
For starters, it promotes transparency and develops trust, which positively impacts the patient experience. Doctors and patients can give and receive better care due to the rapid and flexible flow of relevant data.
Smart RPMs also can promote virtual engagement as it allows patients to actively and efficiently provide biomarker information at critical times of treatment or as symptoms and new information arise.
Also, we can take it a step further by integrating Artificial Intelligence (AI) to interconnected RPMs as it can advance diagnostics with cross-biomarker analysis. Leveraging connectivity and AI will play a crucial role in the future of medical technology.
Smart RPMs are here to stay, and their demand will continue to grow as adjacent and vertical markets find new ways to leverage the technology. Moving forward, we, product designers and engineers, need to continue optimizing for usability, performance, and connectivity.